Renaissance BioScience Corp. to Receive up to $500,000 R&D Funding from the Government of Canada

Renaissance BioScience Corp. to Receive up to $500,000 R&D Funding from the Government of Canada to advance its next-generation yeast development platform

Renaissance BioScience Corp. (RBSC), a leading global yeast technology company, is pleased to announce that it will receive a multi-year, non-repayable contribution of up to Cdn$500,000 from the National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP). The funding will support the company’s ongoing research and development efforts through the advancement of its proprietary, non-GMO yeast strain development platform.

As part of the company’s ongoing focus to develop innovative non-GMO yeast technology, RBSC is engaged in not only the research and development of novel yeast strains for commercialization, but also the discovery and utilization of advanced technology capable of improving the company’s proprietary strain development platform.

“We are pleased to receive funding from IRAP in support of furthering our next-generation non-GMO yeast development platform,” said Dr. Matthew Dahabieh, Chief Science Officer. “The assistance offered by IRAP is an important catalyst for us to enhance our strain development capabilities and will enable us to take the next step in offering innovative next-generation yeast technology to our customers. We thank the Government of Canada and IRAP and for their support.” 

About Renaissance BioScience Corp.

Renaissance BioScience Corp., a leading global yeast technology company based in Vancouver, Canada, is a privately held applied life sciences company that develops yeast-based platform technologies to solve industrial efficiency and consumer health problems in the food, beverage, alcohol, biofuel and pharmaceutical industries. The wholly owned commercial subsidiaries of Renaissance BioScience Corp. include Renaissance Yeast Inc., which commercializes H2S-preventing wine yeast; Renaissance Ingredients Inc., which commercializes acrylamide-reducing baker’s yeast; and Bright Brewers Yeast Inc., which commercializes beer yeast technologies. 

For further information or to arrange interviews, please contact:
Steve Campbell
Campbell & Company Strategies Inc.
Communications and Public Relations
Vancouver, BC, Canada
01 604-888-5267 

Back to all news